High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
At $1,189, Eli Lilly (LLY) looks set up for roughly 76% of upside over the next three years under a conservative scenario. That is a move large enough to justify digging into where it comes from. Revenue compounding does the work, but the multiple takes a meaningful cut along the way. Here is the operational reality the math is built on.
Johnson & Johnson (NYSE:JNJ) is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the setup leaves little to debate. The stock has already told you what it thinks of the fundamentals, rising nearly 25% year to date and nearly 66% over the past year. Yet the ... The Real Case for Buying Johnson & Johnson (JNJ) Before July 15
A legal career can eventually deliver a six-figure income, but the path is rarely passive. The median annual wage for lawyers was $151,160 in May 2024, and attorneys in higher-paid roles can clear $200,000 or more. The tradeoff is years of training, tuition, billable hours, and pressure that does not disappear when the workday ends. ... This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School
The math on replacing $60,000 of annual income looks simple until you ask a different question. At a 3.5% yield, you need roughly $1.7 million. At 6%, you need about $1 million. At 12%, you need around $500,000. Three tiers, three price tags, and three very different risk profiles. The trap is treating that choice ... The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000
Ten years ago, a buyer of Lowe’s (NYSE:LOW) could pick up shares near $66 and collect a quarterly dividend that rose to $0.35 later in 2016. Today, the same share pays $1.25 per quarter, and the stock recently traded near $222. A decade of raises turned a modest-yield holding into a much larger paycheck on ... The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year
Big banks kick off earnings season this week, which will also bring reports from GE Aerospace, Netflix, and Taiwan Semi. In economic news, we’ll get the consumer and producer price indexes, and retail sales data.
Two retirees can both pull $100,000 from $2 million income portfolios and still land in very different places after tax. If one stream is mostly qualified dividends and the other is mostly ordinary income, the first retiree may keep about $79,000 after a 15% federal qualified-dividend rate and 6% state tax. The second may keep ... Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes
A 10% dividend feels like a win because it solves the income problem with less capital. The arithmetic is seductive: $80,000 of annual income requires $800,000 at a 10% yield versus about $2.29 million at 3.5%. The catch shows up five, ten, and twenty years later. A fixed high yield may pay more today, but ... The Dividend Growth Plan That Leaves High-Yield Stocks Behind
A stock screener sorted by current yield misses one of the most powerful income stories in the market. Microsoft (NASDAQ: MSFT) now pays $0.91 per quarter, up from $0.08 per quarter in 2005. Visa (NYSE: V) most recently paid $0.67 per quarter, and its annual dividend now totals $2.68. Those stocks do not look like ... Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine
Most retirement budgets start with the wrong question. The instinct is to ask, “What yield do I need so the nest egg covers the bills?” Higher yield shrinks the required capital, so the math seduces you toward 8%, 10%, or 12% strategies. Punch in the numbers, write down the smaller portfolio target, and breathe easier. ... The Retirement Budget Most People Build Is Backward
Most investors panic when stocks turn red, but the losses that actually destroy wealth rarely show up on a bad trading day. Four household-name stocks reveal the quieter threats compounding beneath the surface.
There are good reasons to invest in Lilly and to hold off.
The big banks dominate this week's reporting docket, though several notable companies from other sectors will also report, including Netflix, Johnson & Johnson, and others. With the outlook trending consistently higher, will companies be able to live up to expectations?
The Illinois Appellate Court upheld a $45 million talc verdict against Johnson & Johnson. The decision confirms the original jury finding in a talc related case rather than reducing or overturning it. The ruling may influence expectations around ongoing talc litigation and future legal outcomes for the company. For investors following Johnson & Johnson (NYSE: JNJ), this legal outcome arrives while the stock trades at $256.98. The company has recorded a 7.8% return over the past 30 days and...
Replacing $7,500 a month with dividends is a math problem before it is anything else. The number you need to invest depends almost entirely on the yield you chase, and each yield tier carries a different set of tradeoffs that reveal themselves only after you own the position for a decade. Across three broad approaches, ... Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead
Rescuing a dog or cat can easily turn into a 10- to 20-year financial commitment. Medium-sized dogs often live around 10 to 13 years, while many cats live into their mid-teens and some stretch past 18. The bill that comes with that lifespan is the part many owners never total, because the monthly receipts feel ... A Dividend Portfolio That Pays For Your Pets
A single weak jobs report moved more money on Wall Street on Monday than any independent company's earnings ever could. That is what played out on Monday, July 6, 2026, and Jim Cramer thinks it handed patient investors a rare opening. The CNBC host argues that big investment funds sold off shares ...
Moderna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors scrambling to understand whether the biotech sector's monster 2026 run has finally hit a wall.
JNJ and AbbVie both beat revenue expectations in Q1 2026, yet their strategies could not look more different, and which playbook actually wins depends entirely on what kind of investor you are.
A dividend cut does not announce itself in advance, but the warning signs appear in the financials long before management steps up to the microphone. Morningstar's index strategists built a three-signal framework to spot the vulnerable payers before the bad news drops.
U. S. stock futures traded little changed on Friday as investors paused after Thursday’s technology-led rally, shifting their attention toward next week’s corporate earnings reports and key inflation releases.
Beyond analysts' top-and-bottom-line estimates for Johnson & Johnson (JNJ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
A long-term care policy does not just protect against a future care bill. It also creates a premium bill that may have to be paid for decades. A healthy 55-year-old buying meaningful inflation protection can face annual premiums in the low-to-mid thousands, and a 55-year-old couple can easily cross $5,000 combined. The planning question is: ... What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?
An investor who bought Microsoft (NASDAQ:MSFT) ten years ago paid closer to $50 per share than $45. Those shares now pay $3.64 per year in dividends, based on Microsoft’s current $0.91 quarterly payout. That is a yield on cost of roughly 7%, even though the stock’s current yield is about 1%. The starting yield helped, ... The 20-Year Dividend Strategy Built For Investors Who Don’t Need Income Yet
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
